← FDA DRUG APPROVALS

FDA ANDA · ANDA077645

ZONISAMIDE

Sponsor: AUROBINDO PHARMA LTD

APPLICATION
ANDA077645
TYPE
ANDA
ORIGINAL APPROVAL
2005-12-22
LATEST ACTION
2023-03-08
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

ZONISAMIDEPrescription
ZONISAMIDE 50MG · CAPSULE · ORAL
ZONISAMIDEPrescription
ZONISAMIDE 100MG · CAPSULE · ORAL
ZONISAMIDEPrescription
ZONISAMIDE 25MG · CAPSULE · ORAL

Approval history

2023-03-08Labeling · Supplement 6 · standardAP
2023-03-08Labeling · Supplement 7 · standardAP
2012-05-30Labeling · Supplement 4AP
2010-09-29Labeling · Supplement 3AP
2010-02-26Labeling · Supplement 2AP
2005-12-22OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →